Garber AJ - Search Results

1

Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center.

Goss JA, Goodpastor SE, Brunicardi FC, Barth MH, Soltes GD, Garber AJ, Hamilton DJ, Alejandro R, Ricordi C. Goss JA, et al. Among authors: garber aj. Transplantation. 2004 Feb 15;77(3):462-6. doi: 10.1097/01.TP.0000100397.86756.A3. Transplantation. 2004. PMID: 14966428

2

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C. Goss JA, et al. Among authors: garber aj. Transplantation. 2002 Dec 27;74(12):1761-6. doi: 10.1097/00007890-200212270-00020. Transplantation. 2002. PMID: 12499894

3

Current standards of care for inpatient glycemic management and metabolic control: is it time for definite standards and targets?

Garber AJ, Seidel J, Armbruster M. Garber AJ, et al. Endocr Pract. 2004 Mar-Apr;10 Suppl 2:10-2. doi: 10.4158/EP.10.S2.10. Endocr Pract. 2004. PMID: 15251634

4

Standards of care for diabetes management reduce complications.

Garber AJ. Garber AJ. Tex Med. 1996 Nov;92(11):23. Tex Med. 1996. PMID: 8942285 No abstract available.

5

Role of insulin signaling in maintaining energy homeostasis.

Sharma MD, Garber AJ, Farmer JA. Sharma MD, et al. Among authors: garber aj. Endocr Pract. 2008 Apr;14(3):373-80. doi: 10.4158/EP.14.3.373. Endocr Pract. 2008. PMID: 18463047 Review.

6

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B; LEAD-3 (Mono) Study Group. Garber A, et al. Lancet. 2009 Feb 7;373(9662):473-81. doi: 10.1016/S0140-6736(08)61246-5. Epub 2008 Sep 24. Lancet. 2009. PMID: 18819705 Clinical Trial.

7

Cardiovascular risk and diabetes mellitus management: diagnosis and treatment in special patient populations. Introduction.

Garber AJ. Garber AJ. Am J Med. 2005 Apr;118 Suppl 2:1S-2S. Am J Med. 2005. PMID: 15903288 No abstract available.

8

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.

Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B; LEAD-3 (Mono) Study Group. Garber A, et al. Diabetes Obes Metab. 2011 Apr;13(4):348-56. doi: 10.1111/j.1463-1326.2010.01356.x. Diabetes Obes Metab. 2011. PMID: 21205128 Free PMC article. Clinical Trial.

9

Insulin resistance syndrome. A review.

Vasudevan AR, Garber AJ. Vasudevan AR, et al. Among authors: garber aj. Minerva Endocrinol. 2005 Sep;30(3):101-19. Minerva Endocrinol. 2005. PMID: 16208303 Review.

10

American College of Endocrinology position statement on inpatient diabetes and metabolic control.

Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. Garber AJ, et al. Endocr Pract. 2004 Jan-Feb;10(1):77-82. doi: 10.4158/EP.10.1.77. Endocr Pract. 2004. PMID: 15251626 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters